Skip to main content
Home

Top menu InfoLep

  • About InfoLep

Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2022
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Publications
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Search

Refine your results

Refine your results


Selected filters

  • Reset filters
  • Leprosy review
  • Western Pacific Region (WPR)

Filter by type

  • Publications only

NTD

  • Leprosy (Hansen disease) (98)

Subject

  • Diagnostic tests (1)
  • Quality of life (1)
  • Contacts / Contact tracing (1)
  • Foot wear (1)
  • Tuberculosis (1)
  • Children (1)
  • Wound care (1)
  • Preventive Chemotherapy (PC) (3)
  • Delays in diagnosis (3)
  • Foot-related problems (1)
  • (Social) participation (1)
  • Eye-care (1)
  • Erythema nodosum leprosum - enl (Type 2 reaction) (3)
  • Social Economic Rehabilitation (1)
  • Community-based rehabilitation (cbr) (1)
  • EMIC Scale (1)
  • Oral health (1)
  • Pain management (1)
  • Case detection (3)
  • Classification (1)
  • Complications and reactions (4)
  • Multi-drug therapy (MDT) (3)
  • Uniform multi-drug therapy (U-MDT) (2)
  • Skin related NTDs (1)
  • Epidemiology (1)
  • Diagnosis (5)
  • Treatment (2)
  • Drug resistance (2)
  • Disability (2)
  • Prevention of disability (pod) (2)
  • Self-care (1)
  • Mortality (1)
  • Stigma (1)
  • Mental health (3)
  • Stigma (leprosy related) (4)

Publication Type

  • Article (94)
  • Full text online (95)

Journal

  • (-) Leprosy review (98)

Year of Publication

  • 2019 (3)
  • 2018 (2)
  • 2017 (5)
  • 2016 (7)
  • 2015 (4)
  • 2014 (2)
  • 2012 (4)
  • 2011 (4)
  • 2010 (4)
  • 2009 (6)
  • 2008 (3)
  • 2007 (3)
  • 2006 (2)
  • 2005 (1)
  • 2004 (4)
  • 2003 (3)
  • 2002 (4)
  • 2001 (2)
  • 2000 (4)
  • 1999 (2)
  • 1998 (1)
  • 1997 (2)
  • 1995 (1)
  • 1994 (2)
  • 1993 (2)
  • 1992 (3)
  • 1989 (5)
  • 1982 (1)
  • 1980 (1)
  • 1976 (1)
  • 1975 (1)
  • 1973 (1)
  • 1970 (1)
  • 1968 (1)
  • 1967 (2)
  • 1965 (1)
  • 1964 (1)
  • 1960 (1)
  • 1948 (1)

Language

  • English (98)

Regional focus

  • African Region (AFR) (5)
    • Comoros (1)
    • Ethiopia (1)
    • Ghana (1)
    • Mozambique (2)
    • Tanzania (1)
    • Zimbabwe (1)
  • Region of the Americas (AMR) (5)
    • Antigua and Barbuda (1)
    • Brazil (3)
    • Mexico (1)
    • Trinidad and Tobago (1)
    • USA (1)
  • South-East Asia Region (SEAR) (8)
    • Bangladesh (2)
    • India (7)
    • Indonesia (2)
    • Myanmar (2)
    • Nepal (1)
    • Sri Lanka (1)
  • (-) Western Pacific Region (WPR) (98)
    • Australia (1)
    • Cambodia (2)
    • China (51)
    • French Polynesia (2)
    • Japan (3)
    • Kiribati (1)
    • Korea, South – Republic of Korea (2)
    • Malaysia (6)
    • Marshall Islands (1)
    • Micronesia, Federated States of (1)
    • New Zealand (2)
    • Papua New Guinea (1)
    • Philippines (17)
    • Singapore (2)
    • Taiwan (China) (2)
    • Vietnam (5)

Research Group

  • IDEAL (2)
  • IDRI / Integration of rapid diagnostic tests to facilitate case management of leprosy (May 2015 - April 2019) (1)
  • LRI / Leprosy Research Initiative (1)
 
  • Relevance
  • Date
98 items

Publication

Reflections on the 20th International Leprosy Congress held in Manila, from Sept 10th to 13th, 2019

Leprosy review. 2019; 90 (4) : 482–486.
Download PDF

Publication

Treatment of leprosy wounds with “Jinchuang ointment”, a traditional Chinese herbal medicine complex

Hsu W, Tsai W, Hung S, et al. Leprosy review. 2019; 90 (4) : 460– 468.
Download PDF

Publication

Spatial-temporal dynamics of leprosy in Wuhan, China, 1950 –2017

Chen J, Chen L, Liu M, et al. Leprosy review. 2019; 90 (1) : 46–56.
Download PDF

Publication

The Leprosy Post-Exposure Prophylaxis (LPEP) programme: update and interim analysis

Steinmann P, Cavaliero A, Aerts A, et al. Leprosy review. 2018; 89 (2) : 102-116.
Download PDF

Publication

A case-control study comparing the Dermatology Life Quality Index (DLQI) ratings of patients undergoing leprosy treatment, people cured of leprosy, and controls in Vietnam

Hunt WTNH, Hùng NT, Tru'ò'ng NN, et al. Leprosy review. 2018; 89 (1) : 46-55.
Download PDF

Publication

Active case detection of leprosy among indigenous people in Sarawak, East Malaysia

Utap MS, Kiyu A. Leprosy review. 2017; 88 (4) : 563–567.
Download PDF

Publication

A prospective randomised, double-blind, placebo controlled trial on the effect of extended clofazimine on Erythema Nodosum Leprosum (ENL) in multibacillary (MB) leprosy

Maghanoy AA, Balagon M, Saunderson P, et al. Leprosy review. 2017; 88 (2) : 208–216.
Download PDF

Publication

The meaning of physical activity for older adults with leprosy: A life story inside the wall

Leprosy review. 2017;
Download PDF

Publication

Drug resistance pattern of Mycobacterium leprae from mouse footpad cultivation between 1997 to 2013 in Malaysia

Dalawi I, Tang MM, Osman AS, et al. Leprosy review. 2017; 88 (4) : 463–477.
Download PDF

Publication

Delayed diagnosis of leprosy cases that persist in China

Jian L, Lianchao Y, Shiguo Z, et al. Leprosy review. 2017;
Download PDF

Publication

Tuberculosis and leprosy infections in the Marshallese population of Arkansas, USA.

Cardenas VM, Orloff M, Kaminaga J, et al. Leprosy review. 2016; 87 (1) : 109-12.
Download PDF

Publication

How to improve early case detection in low endemic areas with pockets of leprosy: a study of newly detected leprosy patients in Guizhou Province, People's Republic of China.

Li J, Yang L, Wang Y, et al. Leprosy review. 2016; 87 (1) : 23-31.
Download PDF

Publication

Need for, and acceptability of, rapid diagnostic tests that can facilitate the diagnosis of leprosy.

Duthie M, Orcullo FM, Maghanoy AA, et al. Leprosy review. 2016; 87 (2) : 158-70.
Download PDF

Publication

Results of eight years follow up among multibacillary patients treated with Uniform Multidrug Therapy in China

Liangbin Y, Jianping S, Meiwen Y, et al. Leprosy review. 2016; 87 (30) : 314–321.
Download PDF

Publication

Knowledge and attitudes to leprosy of Pacific People living in New Zealand

Faatoese A, Sikaleti S, Priest P, et al. Leprosy review. 2016; 87 (3) : 368–377.
Download PDF

Publication

Experiences with Thalidomide for Erythema Nodosum Leprosum– a retrospective study

Darlong J, Govindharaj P, Charles D E, et al. Leprosy review. 2016; 87 (2) : 211-220.
Download PDF

Publication

Two cases of leprosy misdiagnosed in a family, one elephantiasis-like with lepromatous leprosy

YU-YING L, Jian L, HUI C, et al. Leprosy review. 2016; 87 (3) : 409–412.
Download PDF

Publication

The decline of leprosy in the Republic of Korea; patterns and trends 1977-2013.

Lee J, Kim J, Nishikiori N, et al. Leprosy review. 2015; 86 (4) : 316-27.
Download PDF

Publication

Non-adherence to steroid therapy in leprosy reaction and neuritis.

Mani S, Darlong J, John A, et al. Leprosy review. 2015; 86 (4) : 356-67.
Download PDF

Publication

Survey on child leprosy patients and problems resulted from the disease in China

Liangbin Y, Shen J, Min Z, et al. Leprosy review. 2015; 86 (1) : 75–79.
Download PDF

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page Next ›
  • Last page Last »

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2022 InfoNTD